Handelsbanken Fonder’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.12M | Buy |
12,267
+700
| +6% | +$121K | 0.01% | 638 |
|
|
2025
Q1 | $1.8M | Sell |
11,567
-2,100
| -15% | -$327K | 0.01% | 690 |
|
|
2024
Q4 | $1.88M | Sell |
13,667
-4,000
| -23% | -$551K | 0.01% | 697 |
|
|
2024
Q3 | $2.64M | Buy |
17,667
+4,200
| +31% | +$627K | 0.01% | 575 |
|
|
2024
Q2 | $1.84M | Buy |
13,467
+1,200
| +10% | +$164K | 0.01% | 611 |
|
|
2024
Q1 | $1.85M | Buy |
12,267
+900
| +8% | +$136K | 0.01% | 626 |
|
|
2023
Q4 | $1.43M | Hold |
11,367
| – | – | 0.01% | 659 |
|
|
2023
Q3 | $1.06M | Buy |
11,367
+2,367
| +26% | +$222K | 0.01% | 701 |
|
|
2023
Q2 | $803K | Buy |
9,000
+500
| +6% | +$44.6K | ﹤0.01% | 829 |
|
|
2023
Q1 | $911K | Buy |
8,500
+1,400
| +20% | +$150K | 0.01% | 732 |
|
|
2022
Q4 | $867K | Sell |
7,100
-2,500
| -26% | -$305K | 0.01% | 703 |
|
|
2022
Q3 | $991K | Hold |
9,600
| – | – | 0.01% | 662 |
|
|
2022
Q2 | $892K | Sell |
9,600
-100
| -1% | -$9.29K | 0.01% | 733 |
|
|
2022
Q1 | $1.14M | Hold |
9,700
| – | – | 0.01% | 742 |
|
|
2021
Q4 | $1.31M | Sell |
9,700
-900
| -8% | -$121K | 0.01% | 774 |
|
|
2021
Q3 | $1.69M | Buy |
10,600
+1,300
| +14% | +$207K | 0.01% | 673 |
|
|
2021
Q2 | $1.22M | Hold |
9,300
| – | – | 0.01% | 812 |
|
|
2021
Q1 | $1.2M | Sell |
9,300
-1,000
| -10% | -$129K | 0.01% | 763 |
|
|
2020
Q4 | $1.72M | Buy |
10,300
+1,600
| +18% | +$267K | 0.01% | 637 |
|
|
2020
Q3 | $1.34M | Hold |
8,700
| – | – | 0.01% | 634 |
|
|
2020
Q2 | $1.29M | Buy |
+8,700
| New | +$1.29M | 0.01% | 618 |
|